Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Contezolid | 1112968-42-9 | 99.37% | 408.33 | 1 MG
SDP

Supplier:  Medchemexpress LLC HY199151MG

Encompass_Preferred

Contezolid is a new, orally active oxazolidinone antibiotic currently being studied for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. It significantly reduces the potential for myelosuppression and monoamine oxidase inhibition (MAOI).

  • New and orally active oxazolidinone antibiotic.
  • In study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria.
  • Markedly reduces potential for myelosuppression.
  • Markedly reduces potential for monoamine oxidase inhibition (MAOI).
  • Highly potent against all Gram-positive clinical isolates of staphylococci, streptococci, and enterococci, including MDR organisms such as MRSA, methicilline-resistant *Staphylococcus epidermidis* (MRSE), penicillin-resistant Streptococci (PRSP), and VRE.
  • Rapid oral absorption in mouse, rat, and dog.
  • Exhibits no obvious toxicity.

Catalog No. 50-004-03338


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.